Australia's Challenger says revised Daiichi Life takeover offer falls short
Nov 19 (Reuters) - Challenger CGF.AX said on Thursday it had rejected a revised takeover proposal from a unit of Japanese insurer Daiichi Life 8750.T, valuing the Australian investment manager at A$8.17 billion ($5.48 billion).
The revised bid for the remaining 79.5% of shares Daiichi Life does not already own in Challenger is A$12.20 per share, a 2.1% premium to the stock's last close and above Daiichi's earlier offer of A$11.80.
Challenger's board said the revised offer from Daiichi Life does not "adequately represent fair value" for shareholders in the context of a control transaction.
TAL Daiichi Life Australia Pty owns a 20.47 % stake in Challenger, according to LSEG data. Daiichi Life, through the unit, had initially acquired a 15.1% minority stake in Challenger from MS&AD Insurance Group Holdings in April 2025.
Daiichi Life did not immediately respond to a Reuters request for comment.
($1 = 1.4896 Australian dollars)